Experimental Allergic Encephalitogenic Peptide (human)
CAS No. 29705-92-8
Experimental Allergic Encephalitogenic Peptide (human)( ——— )
Catalog No. M39925 CAS No. 29705-92-8
Experimental allergic encephalitogenic peptide (human) is a EAE peptide. Experimental allergic encephalitogenic peptide (human) induces encephalomyelitis in guinea pigs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameExperimental Allergic Encephalitogenic Peptide (human)
-
NoteResearch use only, not for human use.
-
Brief DescriptionExperimental allergic encephalitogenic peptide (human) is a EAE peptide. Experimental allergic encephalitogenic peptide (human) induces encephalomyelitis in guinea pigs.
-
DescriptionExperimental allergic encephalitogenic peptide (human) is a EAE peptide. Experimental allergic encephalitogenic peptide (human) induces encephalomyelitis in guinea pigs.
-
In Vitro———
-
In VivoExperimental allergic encephalitogenic peptide (human) (30 μg; intracutaneous injection; once) with Freund adjuvant induces the onset of encephalomyelitis on day 9-19 after the injection in guinea pigs, the lethality is 33%.
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number29705-92-8
-
Formula Weight1037.11
-
Molecular FormulaC46H64N14O14
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
MM0299
MM0299 is brain permeable, has anti-glioblastoma activity, inhibits lanosterol synthase (LSS), and induces EPC production in in situ GBM tumors.
-
pGlu-Gln-Arg-Leu-Gly...
pGlu-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val is a peptides.
-
8-Hydroxyguanosine
8-hydroxyguanosine (8-OHG) is a marker for measuring the rate of oxidative damage to nucleic acids and lipids.The concentration of 8-OHG in CSF in Parkinson's disease (PD) patients is approximately three-fold that in controls. The concentration of 8-OHG in CSF decreased significantly with the duration of disease. However, the concentration of 8-OHG in serum was not significantly altered in PD patients compared to that in controls.
Cart
sales@molnova.com